ReadCoor is leading the next generation of 'omics' by delivering the first panomic spatial sequencing platform to the global audience of researchers, clinicians, pharma and diagnostics companies, and ultimately patients. It is accomplishing this with a fundamental new technology called FISSEQ which simultaneously enables integration of high throughput sequencing, morphometric analysis, cellular location and three dimensional spatial imaging.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/29/16 | $23,000,000 | Series A |
Decheng Capital Hansjorg Wyss Lilly Asia Ventures Vivo Capital | undisclosed |
